MedPath

Genetic, age, gender and environmental factors that modify immuno-responses and the development of allergic asthma during the school age in childhood.

Conditions
J45
Asthma
Registration Number
DRKS00004927
Lead Sponsor
niversitätsklinikum ErlangenAnästhesieAbteilung Molekulare Pneumologie
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
20
Inclusion Criteria

Written informed consent from the child’s parents/guardian’s
- Age 6-10 years (beginning at the day of the 6th birthday and ending at the day of the 10th birthday)
- Gestational age 36 weeks or above
- A diagnosis of allergic asthma within the last 2 years or bronchial hyperreactivity
- The child is able to perform a body plethysmography
- The legal custodian has the verbal, writing and mental ability to understand the intent and character of the study
Control group:
- Age 6-10 years
- No history of allergic asthma and bronchial hyperreactivity

Exclusion Criteria

- Severe/brittle asthma
- Other chronic respiratory diseases (CF, BPD, immunodeficiencies) except allergic rhinitis
- Other chronic diseases or chronic medication use except atopic exzema

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
WHAT: Genexpression from blood lymphocytes(Array Human Genetic)<br>WHEN: one-time test
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath